BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1070154)

  • 21. Absence of the influence of age on remission rate and duration of remission in a group of thirty-four patients with acute myeloid leukaemia.
    De Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H; De Vries-Hospers HG
    Neth J Med; 1980; 23(6):241-5. PubMed ID: 6936611
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 23. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic hypophosphatemia secondary to 5-azacytidine therapy of acute nonlymphocytic leukemia.
    Ho M; Bear RA; Garvey MB
    Cancer Treat Rep; 1976 Sep; 60(9):1400-2. PubMed ID: 65224
    [No Abstract]   [Full Text] [Related]  

  • 25. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C; Inzoli MR
    G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
    Kurrle E; Hoelzer D; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of the acute leukemias.
    Bernard J; Jacquillat C; Weil M
    Semin Hematol; 1972 Apr; 9(2):181-91. PubMed ID: 4553226
    [No Abstract]   [Full Text] [Related]  

  • 30. Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival.
    Bennett JM; Begg CB
    Cancer Res; 1981 Nov; 41(11 Pt 2):4833-7. PubMed ID: 6945906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative results obtained in the treatment of acute lymphoid leukemia, acute myleoid leukemia, and acute monocytoid leukemia.
    Schwarzenberg L; Mathé G; Pouillart P; Weiner R; Hayat M; Amiel JL; Jasmin C; Rosenfeld C; De Vassal F; Schneider M; Cattan A
    Recent Results Cancer Res; 1973; 43():160-4. PubMed ID: 4531076
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of a new relapse treatment for acute myeloid leukemia (AML) on in vitro granulopoiesis.
    Müller MR; Sauter C; Erni J; Martz G
    Anticancer Res; 1983; 3(2):127-31. PubMed ID: 6573868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytostatic therapy in haemoblastoses].
    Böhnel J
    Wien Med Wochenschr; 1976 Jan; 126(5):54-8. PubMed ID: 948910
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myeloid leukemia in the adult.
    di Cato MA
    Bull Soc Sci Med Grand Duche Luxemb; 1975 Nov; 112(2):129-33. PubMed ID: 1060522
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute non-lymphoid leukemias: comparison of two protocols.
    Hauptmann E; Stacher A; Heinz R; Jaksic B
    Osterr Z Onkol; 1977 Dec; 4(4):80-2. PubMed ID: 271937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Letter: New combination drug therapy of acute myeloid leukemia].
    Fière D; Bryon PA; Martin C; Péaud PY
    Nouv Presse Med; 1975 Sep; 4(29):2114 (1). PubMed ID: 1058467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progress in the treatment of acute leukemias].
    Cavalli F
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1233-8. PubMed ID: 276922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experiences with VP-16 in combination with cyclophosphamide or adriamycin in the anaplastic, predominantly small cell bronchogenic carcinoma].
    Schmieder HA; Jungi WF; Mayr AC; Senn HJ
    Schweiz Med Wochenschr; 1979 Jun; 109(22):841-4. PubMed ID: 462156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.